235 related articles for article (PubMed ID: 19429103)
1. Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat.
Szabadfi K; Atlasz T; Reglodi D; Kiss P; Dányádi B; Fekete EM; Zorrilla EP; Tamás A; Szabó K; Gábriel R
Neurosci Lett; 2009 May; 455(1):42-5. PubMed ID: 19429103
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
[TBL] [Abstract][Full Text] [Related]
3. Urocortin 2 treatment is protective in excitotoxic retinal degeneration.
Szabadfi K; Kiss P; Reglodi D; Fekete EM; Tamas A; Danyadi B; Atlasz T; Gabriel R
Acta Physiol Hung; 2014 Mar; 101(1):67-76. PubMed ID: 24311224
[TBL] [Abstract][Full Text] [Related]
4. Complex neurodegeneration in retina following moderate ischemia induced by bilateral common carotid artery occlusion in Wistar rats.
Yamamoto H; Schmidt-Kastner R; Hamasaki DI; Yamamoto H; Parel JM
Exp Eye Res; 2006 May; 82(5):767-79. PubMed ID: 16359664
[TBL] [Abstract][Full Text] [Related]
5. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
Tanaka M; Telegdy G
Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
9. Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.
Mayor-Torroglosa S; De la Villa P; Rodríguez ME; López-Herrera MP; Avilés-Trigueros M; García-Avilés A; de Imperial JM; Villegas-Pérez MP; Vidal-Sanz M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3825-35. PubMed ID: 16186370
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective action of urocortin in early pre- and postconditioning.
Cserepes B; Jancsó G; Gasz B; Rácz B; Ferenc A; Benkó L; Borsiczky B; Kürthy M; Ferencz S; Lantos J; Gál J; Arató E; Miseta A; Wéber G; Róth E
Ann N Y Acad Sci; 2007 Jan; 1095():228-39. PubMed ID: 17404036
[TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models.
Kalesnykas G; Tuulos T; Uusitalo H; Jolkkonen J
Neuroscience; 2008 Aug; 155(3):937-47. PubMed ID: 18640247
[TBL] [Abstract][Full Text] [Related]
12. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
Ohata H; Shibasaki T
Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
[TBL] [Abstract][Full Text] [Related]
13. Microinjection of urocortin into the rat nucleus tractus solitarii decreases arterial blood pressure.
Yamazaki T; Waki H; Kohsaka A; Nakamura T; Cui H; Yukawa K; Maeda M
Auton Neurosci; 2008 Nov; 142(1-2):51-4. PubMed ID: 18804421
[TBL] [Abstract][Full Text] [Related]
14. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
15. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
16. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
[TBL] [Abstract][Full Text] [Related]
18. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.
Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470
[TBL] [Abstract][Full Text] [Related]
19. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
Czimmer J; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
[TBL] [Abstract][Full Text] [Related]
20. Urocortin does not reduce the renal injury and dysfunction caused by experimental ischaemia/reperfusion.
Patel NS; Collin M; Thiemermann C
Eur J Pharmacol; 2004 Aug; 496(1-3):175-80. PubMed ID: 15288588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
